These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21063201)

  • 1. Inhibiting aberrant Stat3 function with molecular therapeutics: a progress report.
    Haftchenary S; Avadisian M; Gunning PT
    Anticancer Drugs; 2011 Feb; 22(2):115-27. PubMed ID: 21063201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein.
    Fletcher S; Drewry JA; Shahani VM; Page BD; Gunning PT
    Biochem Cell Biol; 2009 Dec; 87(6):825-33. PubMed ID: 19935868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein.
    Debnath B; Xu S; Neamati N
    J Med Chem; 2012 Aug; 55(15):6645-68. PubMed ID: 22650325
    [No Abstract]   [Full Text] [Related]  

  • 4. Signal transducer and activator of transcription 3 inhibitors: a patent review.
    Page BD; Ball DP; Gunning PT
    Expert Opin Ther Pat; 2011 Jan; 21(1):65-83. PubMed ID: 21114420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
    Duan Z; Bradner J; Greenberg E; Mazitschek R; Foster R; Mahoney J; Seiden MV
    Mol Pharmacol; 2007 Nov; 72(5):1137-45. PubMed ID: 17675586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [STAT3 inhibitor].
    Kitamura T
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):19-22. PubMed ID: 21368456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy.
    Masciocchi D; Gelain A; Villa S; Meneghetti F; Barlocco D
    Future Med Chem; 2011 Apr; 3(5):567-97. PubMed ID: 21526897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtubule-targeted chemotherapeutic agents inhibit signal transducer and activator of transcription 3 (STAT3) signaling.
    Walker SR; Chaudhury M; Nelson EA; Frank DA
    Mol Pharmacol; 2010 Nov; 78(5):903-8. PubMed ID: 20693278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies and Approaches of Targeting STAT3 for Cancer Treatment.
    Furtek SL; Backos DS; Matheson CJ; Reigan P
    ACS Chem Biol; 2016 Feb; 11(2):308-18. PubMed ID: 26730496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution.
    Aggarwal BB; Sethi G; Ahn KS; Sandur SK; Pandey MK; Kunnumakkara AB; Sung B; Ichikawa H
    Ann N Y Acad Sci; 2006 Dec; 1091():151-69. PubMed ID: 17341611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
    Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E
    Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting aberrant signal transducer and activator of transcription protein activation with tetrapodal, small molecule Src homology 2 domain binders: promising agents against multiple myeloma.
    Page BD; Croucher DC; Li ZH; Haftchenary S; Jimenez-Zepeda VH; Atkinson J; Spagnuolo PA; Wong YL; Colaguori R; Lewis AM; Schimmer AD; Trudel S; Gunning PT
    J Med Chem; 2013 Sep; 56(18):7190-200. PubMed ID: 23968501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of small molecule inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening.
    Zhang M; Zhu W; Ding N; Zhang W; Li Y
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2225-9. PubMed ID: 23434226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity.
    Dourlat J; Liu WQ; Sancier F; Edmonds T; Pamonsinlapatham P; Cruzalegui F; Garbay C
    Biochimie; 2009 Aug; 91(8):996-1002. PubMed ID: 19470402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer.
    Santoni M; Massari F; Del Re M; Ciccarese C; Piva F; Principato G; Montironi R; Santini D; Danesi R; Tortora G; Cascinu S
    Expert Opin Investig Drugs; 2015 Jun; 24(6):809-24. PubMed ID: 25746129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
    Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT proteins: novel molecular targets for cancer drug discovery.
    Turkson J; Jove R
    Oncogene; 2000 Dec; 19(56):6613-26. PubMed ID: 11426647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors.
    Mankan AK; Greten FR
    Expert Opin Investig Drugs; 2011 Sep; 20(9):1263-75. PubMed ID: 21751940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.